Crossmark

Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial

Crossref DOI link: https://doi.org/10.1186/s12981-017-0134-2

Published Online: 2017-02-04

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Decloedt, Eric H.

Lesosky, Maia

Maartens, Gary

Joska, John A.
Clinical Trials ^BETA

Clinical trials referenced in this document:

pactr201310000635418 at Pan African Clinical Trial Registry

Documents that mention this clinical trial

Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial
https://doi.org/10.1186/s12981-017-0134-2
Funding

Funding for this research was provided by:

European and Developing Countries Clinical Trials Partnership (SP.2011.41304.065)
License Information

Text and Data Mining valid from 2017-02-04

Version of Record valid from 2017-02-04
More Information

Article History

Received: 8 November 2016

Accepted: 13 January 2017

First Online: 4 February 2017

Document is current

Any future updates will be listed below